BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walker MC, Kullmann DM. Optogenetic and chemogenetic therapies for epilepsy. Neuropharmacology 2020;168:107751. [PMID: 31494141 DOI: 10.1016/j.neuropharm.2019.107751] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Löscher W, Klein P. The feast and famine: Epilepsy treatment and treatment gaps in early 21st century. Neuropharmacology 2020;170:108055. [PMID: 32199986 DOI: 10.1016/j.neuropharm.2020.108055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Stafstrom CE. Using the TTX Model to Better Understand the Pathophysiology of a DREADDed Epilepsy-Infantile (Epileptic) Spasms. Epilepsy Curr 2021;21:129-31. [PMID: 34025292 DOI: 10.1177/1535759721993806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kolesov DV, Sokolinskaya EL, Lukyanov KA, Bogdanov AM. Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part I. Acta Naturae 2021;13:52-64. [PMID: 34707897 DOI: 10.32607/actanaturae.11414] [Reference Citation Analysis]
4 LaSarge CL, Danzer SC. What do Newborn Granule Cells Do, and When Do They Do It? Epilepsy Curr 2021;21:363-5. [PMID: 34924837 DOI: 10.1177/15357597211027012] [Reference Citation Analysis]
5 Turner TJ, Zourray C, Schorge S, Lignani G. Recent advances in gene therapy for neurodevelopmental disorders with epilepsy. J Neurochem 2021;157:229-62. [PMID: 32880951 DOI: 10.1111/jnc.15168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Hyder SK, Forcelli PA. Chronic DREADD Isn't As Bad As It Sounds. Epilepsy Curr 2020;20:157-9. [PMID: 32550837 DOI: 10.1177/1535759720920583] [Reference Citation Analysis]
7 Zhang L, Wang Y. Gene therapy in epilepsy. Biomed Pharmacother 2021;143:112075. [PMID: 34488082 DOI: 10.1016/j.biopha.2021.112075] [Reference Citation Analysis]
8 Streng ML, Krook-Magnuson E. The cerebellum and epilepsy. Epilepsy Behav 2021;121:106909. [PMID: 32035793 DOI: 10.1016/j.yebeh.2020.106909] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
9 Steel TL, Afshar M, Edwards S, Jolley SE, Timko C, Clark BJ, Douglas IS, Dzierba AL, Gershengorn HB, Gilpin NW, Godwin DW, Hough CL, Maldonado JR, Mehta AB, Nelson LS, Patel MB, Rastegar DA, Stollings JL, Tabakoff B, Tate JA, Wong A, Burnham EL. Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2021;204:e61-87. [PMID: 34609257 DOI: 10.1164/rccm.202108-1845ST] [Reference Citation Analysis]
10 Clerke JA, Congiu M, Mameli M. Neuronal adaptations in the lateral habenula during drug withdrawal: Preclinical evidence for addiction therapy. Neuropharmacology 2021;192:108617. [PMID: 34019906 DOI: 10.1016/j.neuropharm.2021.108617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Brennan GP, Henshall DC. MicroRNAs as regulators of brain function and targets for treatment of epilepsy. Nat Rev Neurol 2020;16:506-19. [DOI: 10.1038/s41582-020-0369-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
12 McNeill J, Rudyk C, Hildebrand ME, Salmaso N. Ion Channels and Electrophysiological Properties of Astrocytes: Implications for Emergent Stimulation Technologies. Front Cell Neurosci 2021;15:644126. [PMID: 34093129 DOI: 10.3389/fncel.2021.644126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shen Y, Campbell RE, Côté DC, Paquet ME. Challenges for Therapeutic Applications of Opsin-Based Optogenetic Tools in Humans. Front Neural Circuits 2020;14:41. [PMID: 32760252 DOI: 10.3389/fncir.2020.00041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
14 Oguchi M, Tanaka S, Pan X, Kikusui T, Moriya-Ito K, Kato S, Kobayashi K, Sakagami M. Chemogenetic inactivation reveals the inhibitory control function of the prefronto-striatal pathway in the macaque brain. Commun Biol 2021;4:1088. [PMID: 34531520 DOI: 10.1038/s42003-021-02623-y] [Reference Citation Analysis]
15 Boehm MA, Bonaventura J, Gomez JL, Solís O, Stein EA, Bradberry CW, Michaelides M. Translational PET applications for brain circuit mapping with transgenic neuromodulation tools. Pharmacol Biochem Behav 2021;204:173147. [PMID: 33549570 DOI: 10.1016/j.pbb.2021.173147] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Yu Y, Payne C, Marina N, Korsak A, Southern P, García-Prieto A, Christie IN, Baker RR, Fisher EMC, Wells JA, Kalber TL, Pankhurst QA, Gourine AV, Lythgoe MF. Remote and Selective Control of Astrocytes by Magnetomechanical Stimulation. Adv Sci (Weinh) 2021;:e2104194. [PMID: 34927381 DOI: 10.1002/advs.202104194] [Reference Citation Analysis]
17 Desloovere J, Boon P, Larsen LE, Goossens MG, Delbeke J, Carrette E, Wadman W, Vonck K, Raedt R. Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model. Neurotherapeutics 2021. [PMID: 34862591 DOI: 10.1007/s13311-021-01160-0] [Reference Citation Analysis]
18 Adamczyk AK, Zawadzki P. The Memory-Modifying Potential of Optogenetics and the Need for Neuroethics. Nanoethics 2020;14:207-25. [DOI: 10.1007/s11569-020-00377-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]